PCOS ➜ PMOS: The name finally caught up with the condition.

For decades, millions of women were handed a four-word diagnosis that pointed at the wrong thing. Last week, after fourteen years of work and input from 22,000 people, that changed. This is what the rename actually means for the women who have been carrying this condition, often quietly and alone.

What happened last week

If you have been diagnosed with polycystic ovarian syndrome (PCOS) at any point in your life, or if you have spent years suspecting you might have it, I want to tell you about something that was published last week in one of the most respected medical journals in the world.

After fourteen years of collaboration between clinicians, researchers, and women living with the condition; consulting 22,000 people across multiple countries, a global consortium officially renamed polycystic ovary syndrome. It is now called polyendocrine metabolic ovarian syndrome, or PMOS. The change was presented at the European Congress of Endocrinology and published in The Lancet simultaneously. It is not a proposal or a suggestion. It is done.

When I read about it, I did not find myself particularly surprised. What I felt was something closer to relief, and something closer still to recognition. The kind of quiet satisfaction that comes when the rest of the room finally sees what a smaller group of people have been pointing at for a very long time. Why, because the women I work with through Hurmonaat, and the women who came before them in years of clinical medicine, have always known that what they were living with was bigger and more complex than a name about cysts on ovaries ever captured, but their diagnosis didn't add up to it.

Why the old name was always the wrong name

To understand why this rename matters, it helps to understand what the old name was actually saying and what it was leaving out.

Polycystic ovarian syndrome suggests, fairly directly, that the central feature of the condition is the presence of cysts on the ovaries. This created a problem from the very beginning, because those cysts are not actually cysts in the way most people understand the word. They are arrested follicles, i.e. eggs that began the maturation process and then stalled, never completing their development or being released. More importantly, not every woman with the condition even has them. A woman can have every metabolic and hormonal feature of the condition without a single cyst appearing on an ultrasound scan. Which means that for years, women who didn't fit that one visual criteria were sent away undiagnosed, while the actual mechanisms driving their symptoms continued unchecked.

The name also pointed toward the ovaries as the origin of the problem, and yes the ovaries are involved, but they are not where the story begins. Think of it this way: if a factory is producing faulty goods, you can keep inspecting the goods, but until you look at what instructions the factory is receiving, nothing fundamentally changes. The ovaries in PMOS are the factory. The instructions they are receiving from insulin, from androgens, from a disrupted metabolic environment, that is where the condition actually lives. The old name had everyone looking at the goods.

This mattered clinically because the name shaped the care. When a condition is named after ovaries, the specialist you are sent to is a gynaecologist. When the gynaecologist looks for cysts and finds none (ps: the diagnostic criteria requires 2 out of 3 classic signs/symptoms), you are sometimes sent home. When the primary framing is reproductive, the conversation centers on periods and fertility, and the insulin resistance, the elevated androgen levels, the cardiometabolic risk are treated as secondary concerns rather than the core of the problem. The fragmented, incomplete care that so many women with this condition have experienced was not accidental, but rather baked into the name.

What the new name is actually saying

Polyendocrine metabolic ovarian syndrome is a longer name, and a more precise one, and every word in it is doing real work.

Polyendocrine means that this is a condition involving multiple hormones in conversation with each other, not one hormone misbehaving in isolation. Insulin, androgens, cortisol, the hormones that govern the stress response and the hunger response and the sleep cycle, all of these are part of the same disrupted system. The condition is not a single instrument playing out of tune, it is an orchestra where several sections have lost the same conductor.

It is not a single instrument playing out of tune. It is an orchestra where several sections have lost the same conductor.

Metabolic means that insulin resistance is not a secondary feature or a complication that might develop later. It is central to the condition. The risk of type 2 diabetes, of cardiovascular disease, of dyslipidaemia, these are not things that happen to women with PMOS down the line if they are unlucky. They are downstream expressions of the same metabolic disruption that is producing the facial hair and the irregular cycles and the fatigue right now, today. Naming it metabolic means clinicians are now accountable for addressing it metabolically, not just gynaecologically.

Ovarian acknowledges that the ovaries are part of the picture. But they are named last, which is exactly where they belong in the order of causation.

What the new name does, in short, is widen the lens. It asks every clinician, every specialist, every woman sitting in a waiting room with a folder of results to look at the whole system rather than one organ. It validates what a relatively small group of researchers, practitioners, and patients have been saying for years: that this condition was always bigger than its name, and the women living with it deserved a framework that reflected that.

What this means for you, right now

The rename changes what women will be told going forward. It does not automatically change what women who were diagnosed under the old framework have already received, or failed to receive, in the way of explanation and genuine care.

Many women reading this will have been diagnosed years ago, handed a leaflet, told to lose weight or take the pill, and sent back into their lives with a name but no map. The rename does not undo that experience. What it does is confirm that the gap you felt between what you were told and what you were living was real. The map was always incomplete. The condition was always more than the name described. You were right to feel that something was missing.

Hurmonaat was built on the understanding that PMOS is a whole-system condition requiring a whole-system response, well before the rest of the world formalized that in a name change. The programme addresses nutrition, movement, sleep, stress, and environmental factors not because that is a thorough approach but because each of those domains is a direct input into the metabolic and hormonal system that drives the condition. Understanding why is the foundation of everything we do together.

If you were diagnosed with PCOS and never had the metabolic mechanism explained to you, that is not a gap you have to continue living with.

---

Hurmonaat's 2nd cohort starts in July, and a small number of spots are available now for women who want to begin the process early.

I work with a deliberately limited number of women at any one time. That is not a marketing line, it is how the programme is designed. The work we do together inside Hurmonaat requires real attention, and real attention has a number. If you are reading this and something in it has named an experience you recognise, I would rather you reach out now than wait until the cohort is full and the moment has passed.

For women who book their discovery call and onboard before 15th June, there is currently a 33% discount on the programme. That window closes on the date, not when it feels convenient.

The first step is a free 30-minute discovery call with me. We talk through your history, your symptoms, what you have already tried and what hasn't worked. If Hurmonaat is the right fit for you, I will tell you honestly. If it isn't, I will say that too.

Book your call here or come and find me at @hurmonaat on Instagram.

Dr Farida Fanda

GP · Founder, Hurmonaat

FanCare Solutions, UAE